News
2026.03.31
Cells that Act as a Command Center Supporting Cancer Immunity Revealed - Saitama Medical University Publishes in Nature’s Sister Journal –
More
2025.12.05
Saitama Medical University has been granted a patent (Japan Patent No. 7781419) for its patent application relating to our core technology, entitled “Immunological biomarkers for predicting the clinical efficacy of cancer immunotherapy.”
More
2024.04.02
Announcement of research presentation on the function of Th7R cells related to cancer immunity at AACR by Professor Kagamu of Saitama Medical University
More
2023.10.13
Notice of decision of no grounds for refusal of patent on automated cell population identification technology system
More
2023.07.27
New Location
More
2023.07.24
ImmuniT Research Inc. selected as one of the top 3 award-winning companies in the KLSAP acceleration program.
More
2023.06.16
It was reported that the European Patent Office acknowledged patentability of European patent application EP22153621.2, filed on the results of joint research between our company and Saitama Medical University.
More
2023.04.11
Notice regarding Chinese patent grant for our core technology “immunological biomarkers predicting clinical efficacy of cancer immunotherapy”
More
2022.11.10
A patent (JP7175068) was granted in Japan to Saitama Medical University for the patent application “Biomarker for predicting response to cancer therapy” which is a result of the collaborative research by Saitama Medical University and ImmuniT Research Inc.
More